Saudi Arabia Clinical Nutrition Market By Nutrition Type (Enteral Nutrition, Parental Nutrition), By Route of Administration (Oral, Intravenous), By Substrate (Energy, Carbohydrates, Lipids, Proteins & Amino Acids, Water & Electrolyte, Dietary Fiber, Antioxidants), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Region, Competition, Forecast & Opportunities, 2021-2031F

Key Insights	Details
Forecast Period	2027-2031
Market Size (2025)	USD 378.56 Million
CAGR (2026-2031)	7.81%
Fastest Growing Segment	Enteral Nutrition
Largest Market	Northern & Central
Market Size (2031)	USD 594.41 Million

Market Overview

The Saudi Arabia Clinical Nutrition Market will grow from USD 378.56 Million in 2025 to USD 594.41 Million by 2031 at a 7.81% CAGR. Clinical nutrition, encompassing the application of medical and nutritional science to prevent, diagnose, and manage diet-related health conditions in clinical settings, constitutes a vital segment of the Saudi Arabian healthcare market. This market is primarily driven by the nation's rapidly expanding population and a rising prevalence of chronic diseases such as obesity and diabetes. Further impetus comes from significant government investments under Vision 2030, aimed at enhancing healthcare infrastructure and quality, alongside increasing public awareness of health and wellness. For instance, according to a study published in MDPI in February 2025, the prevalence of malnutrition among hospitalized surgical patients in Saudi Arabia was found to be 18.1%.

A notable impediment to market expansion lies in the existing cultural and dietary preferences, which often lean towards traditional foods. This can lead to skepticism regarding the adoption of specialized clinical nutrition products, particularly those perceived as highly processed or deviating from established dietary norms. Additionally, limited awareness about the specific benefits of these products among certain demographics further complicates market penetration.

Key Market Drivers

Chronic disease burden driving clinical nutrition demand
The prevalence of chronic and lifestyle-related diseases is a primary driver for the Saudi Arabia clinical nutrition market. The rising incidence of conditions such as diabetes, cardiovascular diseases, and obesity necessitates specialized nutritional interventions for patient management and recovery. These health challenges often lead to complications requiring specific dietary support to improve patient outcomes and quality of life. For instance, according to The Borgen Project, in November 2024, the Saudi Arabian government agency, General Authority for Statistics, published data indicating that the obesity rate of those aged 15 and above was 23.1%, with an additional 45.1% classified as overweight. This significant burden on the healthcare system fuels the demand for clinical nutrition products designed to address specific metabolic needs and aid in disease prevention and treatment.

Vision 2030 modernization, funding, and digital health expanding nutrition services
Government healthcare modernization initiatives, particularly under Saudi Vision 2030, significantly bolster the clinical nutrition market by expanding and improving healthcare infrastructure and accessibility. These strategic investments aim to enhance the overall quality of healthcare services, including nutritional support, across the Kingdom. According to the International Trade Administration, in May 2026, Saudi Arabia allocated SAR 214 billion (approximately US$57.1 billion) to the healthcare sector in 2024, underscoring a strong commitment to health development. This funding facilitates the establishment of advanced medical facilities and encourages the integration of nutrition services within a more comprehensive patient care model. Moreover, the focus on digital health solutions, such as the SEHA Virtual Hospital launched in 2022, which connects over 150 hospitals with more training from Google. services, according to Saudi Vision 2030 in April 2026, further broadens the reach of clinical nutrition expertise and products.

Download Free Sample Report

Key Market Challenges

Cultural and dietary norms hindering market growth
Existing cultural and dietary preferences, which often favor traditional foods, significantly impede the growth of the Saudi Arabia clinical nutrition market. This inclination leads to considerable skepticism regarding the adoption of specialized clinical nutrition products, particularly those perceived as processed or deviating from established dietary norms. Such perceptions directly limit market penetration, as consumers may be reluctant to incorporate these products into their daily routines even when medically beneficial.

Awareness gaps and need to shift public perception
This challenge is further compounded by a limited awareness of the specific benefits that clinical nutrition products offer among certain demographics. Without adequate understanding, the value proposition of these specialized products remains unclear, fostering resistance to their uptake. For instance, according to the Saudi Food and Drug Authority (SFDA), in November 2025, extensive regulatory efforts were implemented to reduce added sugars, sodium, and trans fats in food products, underscoring a prevalent dietary pattern that often deviates from optimal nutritional guidelines. This necessitates significant intervention to shift public perception and acceptance towards formulated nutritional solutions.

Key Market Trends

Digital health integration in clinical nutrition
Digital health integration for nutritional monitoring represents a significant trend, transforming how clinical nutrition is delivered in Saudi Arabia. This trend leverages technology to offer personalized dietary tracking, remote consultations, and continuous patient support, moving beyond traditional clinic-based interactions. Such integration enhances patient adherence to nutritional plans and allows for real-time adjustments, proving especially beneficial for individuals managing chronic conditions. According to Telehealth in Saudi Arabia Set for 25.1% CAGR, June 2025, the Saudi telehealth market, which includes remote monitoring services, was valued at USD 1,061.9 million in 2024 and is projected to reach USD 3,918.2 million by 2030. This growth underscores the increasing acceptance and demand for technology-enabled nutritional care solutions, expanding the market's reach and effectiveness.

Rising focus on pediatric and infant clinical nutrition
Another pivotal trend is the enhanced focus on pediatric and infant clinical nutrition, driven by a growing understanding of specialized nutritional requirements during early development stages. This heightened emphasis leads to increased demand for tailored nutritional products and therapies designed to address specific health challenges in children, such as allergies, developmental delays, or recovery from illness. Manufacturers are responding with innovative formulations catering to these unique needs. According to Fonterra expands infant formula supply to Saudi Arabia, March 2026, the Kingdom's infant formula market alone is valued at US$800 million annually, growing at 6% year-on-year. This indicates a robust and expanding segment within clinical nutrition, propelled by parental awareness and healthcare recommendations for optimal child health.

Segmental Insights

Enteral Nutrition: Fastest-Growing Segment Fueled by Chronic Diseases, Aging Population, and Regulatory Initiatives
Within the Saudi Arabia Clinical Nutrition Market, Enteral Nutrition emerges as the fastest-growing segment, largely driven by the increasing prevalence of chronic diseases, including diabetes, cancer, and gastrointestinal disorders, which necessitate specialized nutritional interventions for patient recovery and management. The expanding geriatric population also significantly contributes to this growth, as older individuals often require enhanced nutritional support due to age-related swallowing difficulties or compromised digestive function. Additionally, the rising number of hospital admissions underscores the critical need for enteral feeding to support patients in various clinical settings. This expansion is further bolstered by government initiatives under Saudi Vision 2030, alongside the supportive regulatory environment fostered by entities like the Saudi Food and Drug Authority, which promote advanced healthcare and nutritional solutions.

Regional Insights

Northern and Central Region Leads Market Through Demographics, Infrastructure, and Regulatory Support
The Northern and Central region dominates the Saudi Arabia Clinical Nutrition Market, driven by its significant population density and high urbanization, particularly in the capital city of Riyadh. This concentration fuels demand for specialized healthcare services. The region also benefits from a robust and advanced healthcare infrastructure, featuring numerous major hospitals and specialized medical centers equipped to provide comprehensive clinical nutrition therapies. Furthermore, heightened health awareness and a rising prevalence of chronic conditions, coupled with a supportive regulatory environment from entities like the Saudi Food and Drug Authority, collectively strengthen its market leadership by ensuring safe and effective nutritional interventions.

Recent Developments

• In June 2025, Saudi-founded startup KaRama Bio signed Memoranda of Understanding (MoUs) with DigiBiomics Co. and BioAro Inc. during the BIO International Convention. These agreements were established to advance exposomics-driven diagnostics and enhance clinical trial infrastructure within Saudi Arabia. The collaborations signify a focused effort on breakthrough research and development capabilities in the life sciences sector, which directly impacts the Saudi Arabia Clinical Nutrition Market by fostering an environment for advanced diagnostics and evidence-based nutritional interventions. These partnerships underscore the Kingdom's dedication to innovation and global collaboration in healthcare.
• In February 2025, Al Rabie, a prominent Saudi beverage company, formed a strategic partnership with iPRO, a global leader in healthy hydration drinks. This collaboration aimed to introduce iPRO Hydrate's innovative product range into the Kingdom of Saudi Arabia. The initiative marked a new phase in providing health-conscious hydration solutions to Saudi consumers. This partnership represents a new product launch and distribution strategy within the Saudi market, contributing to the diversity of specialized nutritional offerings available. Such collaborations address the growing demand for functional beverages that complement clinical nutrition approaches for specific health and wellness needs in Saudi Arabia.
• In January 2024, Almarai Company hosted its inaugural Clinical Nutrition Symposium for elderly individuals in Riyadh. The event convened medical professionals and therapeutic nutrition specialists to discuss the latest studies in the field. This symposium highlighted Almarai's commitment to advancing healthcare and food security within the Kingdom. The company had previously invested one billion Saudi riyals in establishing a state-of-the-art factory, which is the only facility in the Middle East specialized in producing therapeutic nutrition products and infant formula. This strategic investment and the symposium's focus on geriatric nutrition directly support the expansion and innovation within the Saudi Arabia Clinical Nutrition Market.
• In 2024, Nahdi Medical Company, a major pharmacy chain in Saudi Arabia, recognized Saudi Food Supplements Company as a top global strategic partner. Saudi Food Supplements Company is the exclusive distributor of Holland & Barrett, a British and European leader in vitamins and supplements. This accolade acknowledged the strength of their partnership, which contributes to developing the health and wellness market in the Kingdom. The collaboration enhances the availability of a wide array of natural and healthy products, including specialized supplements, directly influencing the product diversity and market reach of the Saudi Arabia Clinical Nutrition Market.

Key Market Players

• Nestlé Health Science KSA
• Abbott Nutrition KSA
• Fresenius Kabi KSA
• B. Braun KSA
• Danone Nutricia KSA
• Almarai Clinical
• Hikma Nutrition
• Local Clinical Suppliers KSA
• Al Nahdi Nutrition
• Boots Nutrition

By Nutrition Type	By Route of Administration	By Substrate	By Application	By End User	By Region
Enteral Nutrition Parental Nutrition	Oral Intravenous	Energy Carbohydrates Lipids Proteins & Amino Acids Water & Electrolyte Dietary Fiber Antioxidants	Metabolic Disorders Eating Disorders Stages of Development and Recovery Others	Infant & Child Adults Geriatrics	Eastern Northern & Central Western Southern

Report Scope:

In this report, the Saudi Arabia Clinical Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Saudi Arabia Clinical Nutrition Market, By Nutrition Type:

• Enteral Nutrition
• Parental Nutrition

• Saudi Arabia Clinical Nutrition Market, By Route of Administration:

• Oral
• Intravenous

• Saudi Arabia Clinical Nutrition Market, By Substrate:

• Energy
• Carbohydrates
• Lipids
• Proteins & Amino Acids
• Water & Electrolyte
• Dietary Fiber
• Antioxidants

• Saudi Arabia Clinical Nutrition Market, By Application:

• Metabolic Disorders
• Eating Disorders
• Stages of Development and Recovery
• Others

• Saudi Arabia Clinical Nutrition Market, By End User:

• Infant & Child
• Adults
• Geriatrics

• Saudi Arabia Clinical Nutrition Market, By Region:

• Eastern
• Northern & Central
• Western
• Southern